Iron and lymphocytes: reciprocal regulatory interactions.
de Sousa
M
M
Abel Salazar Institute for the Biomedical Sciences, Oporto, Portugal.
Reimão
R
R
Porto
G
G
Grady
R W
RW
Hilgartner
M W
MW
Giardina
P
P
D000818:Animals; D001815:Bloodletting; D016516:CD4-CD8 Ratio / Q000187:drug effects; D015913:Chelation Therapy; D003676:Deferoxamine / Q000494:pharmacology; D005290:Ferric Compounds / Q000633:toxicity; D006432:Hemochromatosis / Q000139:chemically induced / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D007501:Iron / Q000502:physiology* / Q000633:toxicity; D051379:Mice; D008954:Models, Biological; D051381:Rats; D011919:Rats, Inbred Strains; D011920:Rats, Inbred WF; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000502:physiology*; D013789:Thalassemia / Q000188:drug therapy / Q000503:physiopathology
D005290:Ferric Compounds; C025314:ferric citrate; D007501:Iron; D003676:Deferoxamine